undefined

Chris Aiken, MD

Psychiatrist specializing in bipolar disorder treatment

Top 5 podcasts with Chris Aiken, MD

Ranked by the Snipd community
undefined
46 snips
Mar 25, 2024 • 23min

Deprescribing Anti-anxiety Meds in Older Adults

Dr. Chris Aiken discusses the risks of anti-anxiety medication in older adults, emphasizing the importance of tapering off to reduce adverse effects. Topics include dangers of deprescribing, risks of abrupt discontinuation, navigating anti-psychotic meds in dementia patients, and guidance on tapering and substituting anxiety medications for the elderly.
undefined
15 snips
Feb 12, 2024 • 17min

Auvelity: 4 Controversies

Dr. Chris Aiken and Kellie Newsome discuss controversies around Auvelity, a fast-acting antidepressant, examining side effects, addictive potential, and generic components. They explore the combination of dextromethorphan and bupropion, generic substitution risks, treatment options for resistant depression, and concerns about long-term efficacy and medication use.
undefined
7 snips
Feb 19, 2024 • 22min

Stimulant Dosing

Learn about stimulant dosing in psychiatry with Chris Aiken, MD and Kellie Newsome, PMHNP. Topics include challenges in diagnosing adult ADHD, risks of high stimulant doses, optimal dosing of Adderall XR, maximizing ADHD treatment, exploring methylphenidate dosage and effects.
undefined
Apr 1, 2024 • 13min

Viibryd Goes Generic

Psychiatrist Chris Aiken, MD, and Psychiatric Nurse Practitioner Kellie Newsome discuss the generic form of Vilazodone, exploring its efficacy in managing depression and anxiety disorders, its impact on treating anxious depression, and its tolerability compared to SSRIs. They highlight the importance of understanding the drug's mechanism of action, onset of action, and remission rates from trials and studies.
undefined
Feb 5, 2024 • 17min

Auvelity A Fast Acting Antidepressant

Dr. Aiken and Kellie discuss Auvelity, a fast-acting antidepressant, exploring its pharmacodynamics, benefits of pairing with bupropion, and update on treatment-resistant depression trial. They also delve into Aveleti's efficacy in depression treatment and ongoing studies.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner